A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT06949267 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06949267
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2026-09-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.